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Abstract
Oxidative stress is caused by the imbalance between the amount of reactive 
oxygen species (ROS) and antioxidant capacity in the body. A balanced diet involv-
ing the daily intake of antioxidant-rich foods makes improvements in the total 
antioxidant capacity of individuals and would therefore reduce the incidence of 
oxidation-related diseases. It may also regulate the degree of oxidative stress. In 
fact, dietary micronutrients are either direct antioxidants or components of anti-
oxidant enzymes, which may contribute positively to certain indicators of hepatic 
function. Liver plays an important role in the regulation of various processes such 
as metabolism, secretion, storage, and the clearance of endogenous and exogenous 
substances. Once liver is damaged by pursuing a wrong diet and inflammation takes 
place, most of these physiological functions get altered. Apart from drugs that used 
to treat the ailments, it is also necessary to determine the pharmaceutical alterna-
tives for the drugs that are used in the treatment of liver diseases. Therefore, this 
chapter aims to summarize all known information on the effects of dietary nutri-
ents on oxidative stress in experimental liver models.
Keywords: dietary antioxidant, free radicals, oxidative stress, liver
1. Introduction
The liver is the major organ metabolizing xenobiotics and endogenous molecules 
in order to maintain metabolic homeostasis in the organism, which is why it is 
a target of many toxic substances that cause dysregulated hepatic homeostasis. 
One of the mostly found clinical liver diseases is nonalcoholic fatty liver disease 
(NAFLD) (Figure 1) [2, 3]. In NAFLD, hepatocytes get filled up with triglycerides, 
liver expands and its normal functions may get altered. Although it is a disease, 
the triglyceride accumulation can still be reversed and normal functions may be 
restored by proper nutrition and exercise. If these lifestyle changes are not pursued, 
the damage goes on and results in inflammation followed with fibrosis which is 
unfortunately irreversible.
The liver is made up of hepatocytes, Kupffer cells, liver sinusoidal endothelial 
cells, pit cells, and hepatic stellate cells (HSC) [4]. Activation of stellate cells by injury 
caused by many etiological factors would lead to cirrhosis, and it would mark the 
end stage of progressive fibrosis [5]. Oxidative stress has a vital part in establishing 
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fibrosis and consequently cirrhosis [6]. For this reason, using molecules with 
antioxidant properties has been proposed as a treatment for not only fibrosis but 
also oxidative stress-related cirrhosis. Liver diseases are considered a major medical 
problem worldwide. There are known to be a large number of liver diseases caused 
by different insults. Furthermore, the disease type depends on lifestyle factors. For 
example, the main causes of liver diseases are reported to be viral and parasitic infec-
tions in regions like Africa and Asia. For Europe and America, alcohol consumption 
is thought to be the most important cause of this disease. However, viral hepatitis 
has showed an increase in recent times in most of the countries [7]. Lifestyle and 
unhealthy diet is the leading cause of liver diseases in almost all western countries. 
Until today, no medication is approved for the treatment of this disease; however, 
improving diet habits and physical exercise works if the disease is not accompanied 
by inflammation. On the other hand, biologically active food compounds that regu-
late gene expressions in lipogenesis, fibrosis, and inflammation serve as good thera-
peutic means to ameliorate these pathological states observed in liver [1] (Figure 1).
1.1 Oxidative stress
Oxidative stress is recognized as a disproportion between the production of free 
radicals (FR) and the antioxidant defenses [8]. Increased levels of prooxidants result 
in damage to the cell in terms of lipid peroxidation as well as oxidative DNA damage 
Figure 1. 
Molecular mechanisms explaining the hepatoprotective effect of food bioactives. Development of NAFLD/
NASH is induced by different risk factors, such as Western-type diet, physical inactivity, and genetic 
predisposition. In the presence of obesity and IR, there is an increased flux of FFAs to the liver. These FFAs are 
stored as TG in lipid droplets leading to hepatic fat accumulation or undergo β-oxidation increasing oxidative 
stress and the inflammatory pathway. The damaged hepatocyte leads to a further increase of inflammatory 
signaling (IL-1, TNFa, IL-6) and the recruitment of circulating and residual macrophages (KCs). All of these 
mechanisms can directly induce the activation of HSCs, the major cell type involved in extracellular matrix 
deposition and liver fibrosis. The bioactive compounds may exert beneficial effects on NAFLD development 
and progression by inhibiting lipogenesis, β-oxidation of FFAs, inflammation, and HSCs activation. In the 
cartoon, we have listed the food bioactives indicating the putative mechanisms by which they may improve liver 
damage in NAFLD [1].
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and thus protein damage [9]. One or more unelectrified FR atoms or molecules may 
be present as radical cations or radical anions. They are usually unstable and highly 
reactive because they can react with molecules and abstract electrons. Oxygen can 
reduce and produce reactive oxygen species (ROS) with exciting electrons, secondary 
to the interaction of transition metals or by the addition of energy [9, 10]. Oxidative 
stress causes fibrogenesis by increasing transforming cytokines including transform-
ing grown factor-beta-1 (TGFβ1), interleukin-6 (IL-6), and tumor necrosis factor-
alpha (TNFα) [3]. Disruption of the liver metabolism arises from increased quantity 
of ROS to amplified electron transfer in mitochondrial B-oxidation and increased 
expression and activity of Cyp2el that is from CYP450 family [11]. Intense produc-
tion of Cyp2e1 is present because of much more consumption of ethanol which is 
produced by virtue of a lot of direct and indirect mechanisms [12–14] (Figure 2).
1.2 Basic sources of free radicals
Cells produce FR as a result of metabolic events; however, this is not the only 
source that can cause oxidative stress in body. The pollutants in the environment 
such as toxic chemicals as well as radiation cause a significant increase in amount of 
FR, ROS, and reactive nitrogen species (RNS) [10]. In the body, variety of different 
cell types and chemical reactions produce ROS, the most important metabolism is 
the cytochrome P450 metabolism and mitochondria-catalyzed electron transport 
reactions. Most of the inflammatory conditions are also responsible from ROS 
production, and important cell types in these processes are neutrophils, eosinophils, 
Figure 2. 
Mechanisms of enhanced ROS production during hepatocyte damage. Ethanol metabolism promotes strong 
ROS production in the ER by the inducible CYP. It impairs GSH import in the mitochondria, preventing ROS 
removal. It also impairs B-oxidation promoting lipid accumulation. ETOH induces lipid-raft clustering and 
increases iron uptake, promoting Fe2+ leakage from lysosomes and increased Fe2+ loads in mitochondria and ER, 
resulting in ROS production. Ethanol also reduced the autophagic removal of damaged cellular components. 
Viral infection challenges the ER protein folding process leading to ROS production and Ca2+ leakage in the 
cytosol and mitochondria. Increased MAMs formation promotes Ca2+ efflux from ER into mitochondria, 
increasing mitochondrial ROS production [15].
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and macrophages [16, 17]. The chief molecule responsible for the reduction of oxygen 
in mitochondria is ubisemiquinone. Mitochondria is such an important organelle to 
produce ROS and hydrogen peroxide (H2O2) as it produces 2–3 nmol of superoxide/
min per mg of protein, [17]. Different tissues of mammals and different species of 
mammals have an enzyme called xanthine oxidase, an enzyme belonging to molybde-
num, iron-sulfur, flavin hydroxylases that play an important role in the hydroxylation 
of purines by the oxidation of hypoxanthine to xanthine. Resultant xanthine then 
oxidized to uric acid. Oxygen reduction takes place in both of these reactions and the 
first one produces O2
−, while the second one produces H2O2 [16]. Inflammation serves 
as another source of ROS generation. During inflammation, activated macrophages 
increase their oxygen uptake, and this process results in production of O2
−, nitric 
oxide (NO), and H2O2 [18]. Another mechanism of O2
− production during inflamma-
tion is by neutrophils; the enzyme nicotine adenine dinucleotide phosphate [NAD(P)
H] oxidase generates O2
− that is used to destroy bacteria and this nonphagocytic 
NAD(P)H oxidases produce O2
− in a range of 1–10% [19]. Cytochrome P450 (CYP) 
enzymes are also important in the production of ROS by the breakdown and/or 
uncoupling of the P450 catalytic cycle. Hyperoxia would trigger 80% of the H2O2 
synthesis by microsomes, and under normoxic conditions, peroxisomes produce H2O2 
but not O2
−, and most of the peroxisomal H2O2 production takes place in liver [16]. 
Arginine is reduced to citrulline in a five-electron oxidative reaction by nitric oxide 
synthases (NOSs) and this reaction gives rise to NO. Immune cells can also produce 
NO in the oxidative burst during inflammation. NO can react with oxygen and water 
in an extracellular environment in order to form nitrate and nitrite anions. Also, the 
NO and O2
− can react together and cause a more reactive FR called peroxynitrite 
anion (ONOO−) which can cause lipid peroxidation and fragmentation of DNA [20].
1.3 Antioxidants
Antioxidants are molecules that can help prevent or delay oxidation of an oxidiz-
able substrate when in low concentrations and they have a high affinity to FR [21]. 
Antioxidants play an important role to maintain health of the organism by scav-
enging FR by donating electrons to it. This reduces the reactivity of FR and helps 
maintain prooxidant/antioxidant balance in cell. A lot of different molecules that 
have antioxidant activity have been identified. Different natural compounds have so 
far been studied extensively especially in liver diseases (Table 1).
1.4 Curcumin
Curcumin, diferuloylmethane or 1,7-bis (4-hydroxy-3-methoxyphenyl)1,6- 
hepadieno-3,5-dione is obtained from the rhizomes of Curcuma longa (turmeric). 
Curcumin has many pharmacological properties as it is a strong antioxidant, 
antifibrogenic, anti-inflammatory, antimicrobial, and anticarcinogenic agent and 
it also aids in a wound healing [22]. The Food and Drug Administration (FDA) has 
classified turmeric as a safe substance and toxicity assays done on animals have shown 
curcumin to be safe even when used in high doses. On the other hand, prolonged 
high-dose intake of turmeric has been associated with incidences of hepatotoxicity in 
mice and rats [3]. Curcumin is known to have low bioavailability when administered 
orally. Arcaro et al. [23] used piperine (inhibitor of hepatic and intestinal absorption) 
together with curcumin. Even in the presence of piperine, antidiabetic and antioxidant 
activity of curcumin was not altered. But when higher dose of piperine (40 mg/kg) 
was used, the beneficial effects of curcumin vanished. On the other hand, Sehgal 
et al. [24] showed the effect of piperine on curcumin in benzo(a)pyrene toxicity in 
the liver. They found that pretreatment with 100 mg/kg of curcumin protects against 
5Dietary Antioxidants in Experimental Models of Liver Diseases
DOI: http://dx.doi.org/10.5772/intechopen.83485
Antioxidant Main clinical effects Clinical relevance
Curcumin Antioxidant No studies available in human hepatic disorders
Antifibrotic
Anti-inflammatory
Antimicrobial
Wound healing
Anticarcinogenic
Resveratrol Antioxidant Current data are conflicting, so more clinical 
studies are needed
Anti-inflammatory
Anticarcinogenic
Lipid modulation
Antifibrotic
Coffee Antinecrotic Inverse relationship between coffee-cirrhosis 
has been demonstrated, but more basic research 
and prospective clinical trials are necessary
Antifibrotic
Antioxidant
Anticholestatic
Chemoprotective
Quercetin Chelation of transition metal ions No studies available in human hepatic disorders
Anticarcinogenic
Cardioprotective
Bacteriostatic
Antioxidant
Antifibrotic
Anti-inflammatory
Antiapoptotic
Antiaggregatory
Vasodilating
Silymarin Antioxidant Silymarin has been shown to be effective, but it 
is necessary to do more clinical trials focused on 
survival rates of patients with cirrhosis
Antifibrotic
Anti-inflammatory
Anticarcinogenic
Immunomodulation
Naringenin Antioxidant No studies available in human hepatic disorders
Hypocholesterolemic
Anti-estrogenic
Hypolipidemic
Antihypertensive
Anti-inflammatory
Antifibrotic
Anticarcinogenic
Antiatherogenic
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a single dose of benzo(a)pyrene; and at this dose, coadministration of piperine had 
a much better effect than did curcumin alone showing enhancer activity of piperine. 
In acute and chronic liver injury, curcumin has been shown to have hepatoprotective 
effects [25]. In 2007, Reyes-Gordillo et al. [26] showed that curcumin is able to inhibit 
the release of TNF-α, IL-1B, and IL-6. Additionally, curcumin reduces carbon tetra-
chloride (CC14)-mediated oxidative stress inactivating the nuclear factor-kB (NF-kB) 
pathway. Moreover, curcumin’s hepatoprotective effect takes place by its interactions 
with Fe3+ and Cu2+. A study by Jiao et al. [27] suggested that curcumin could serve as 
an iron chelator since transferrin receptor 1 and iron regulatory proteins, indicators of 
iron depletion, showed an increase with curcumin administration. Charoensuk et al. 
[28] have indicated that curcumin increases antioxidant capacity of cells by increasing 
mRNA and protein levels of factors and enzymes such as nuclear factor erythroid 
2-related factor 2 (Nrf2), heme oxygenase (HO-1), NAD(P)H quinone oxidoreduc-
tase 1 (NQO1), glutamate cysteine ligase (GCL), transcription factor-3, peroxiredoxin 
3 (Prdx3), and Prdx6. Curcumin also increases the activity of glutathione (GSH), 
superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), and 
glutathione-S-transferase (GST) activity [29, 30]. Curcumin also interacts with 
enzymes or genes that are important in liver cirrhosis. Hassan et al. [31] showed that 
curcumin modulates miRNA 199 and 200 which are associated with liver fibrosis in 
CC14-induced experimental fibrosis model and that curcumin reduced these miRNAs 
levels close to their basal levels. Finally, in alcohol-induced liver damage, curcumin 
inhibits the activity of cytochrome P450 2E1 (Cyp2e1) and also its protein levels [32].
1.5 Resveratrol
The phytoalexin resveratrol (3,5,4′-trans-trihydroxystilbene) is a polyphe-
nol mostly found in red grapes, red wine, peanuts, and berries [33]. Resveratrol 
has effects on lipid metabolism, and it also has antioxidant, anti-inflammatory, 
Antioxidant Main clinical effects Clinical relevance
Green tea Anti-inflammatory More clinical studies are needed
Antiarthritic
Antimicrobial
Antioxidant
Neuroprotective
Antidiabetic
Antiangiogenesis
Anticarcinogenic
L-carnitine Chelation of transition metal ions More clinical studies are needed
Antioxidant
Cardioprotective
Neuroprotective
Anti-inflammatory
Lycopene Antioxidant More clinical studies are needed
Anti-inflammatory
Chemoprotective
Anticarcinogenic
Table 1. 
Nutritional antioxidants.
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anticarcinogenic, and antifibrogenic properties [34]. The rate of absorption of resve-
ratrol is about 75% following an oral administration [35]. Resveratrol is metabolized 
to resveratrol sulfate, and in its low concentrations, it is converted into resveratrol 
glucuronide [36] by enzymes glucuronosyltransferase (UGT) or sulfotransferase 
(ST) [37]. In 2007, Chávez et al. [34] showed that under CCl4, resveratrol decreased 
cytokine TGF-β levels and prevented hepatic fibrosis. It also inhibited NF-kB 
translocation to the nucleus. Resveratrol, as an antioxidant, has protective effects 
against ethanol-induced lipid peroxidation, toxicity by acetaminophen (APAP), and 
oxidative stress in animal models of cholestasis [38]. Important player in resveratrol’s 
antioxidant activity is suggested to be run by the OH groups [7]. Blocking OH group 
methylation showed that resveratrol and trimethylated resveratrol provide some 
degree of protection, but the latter one has a better protective effect [39]. Another 
hepatoprotection mechanism of resveratrol comes from its ability to activate genes 
related to antioxidant system or from its ability to inhibit enzymes. A study by Cheng 
et al. [40] suggested that resveratrol could activate extracellular signal-regulated 
kinase (ERK) signaling pathway, which may, in turn, enhance the activation and 
translocation of Nrf2 to the nucleus, thus increasing the expression of HO-1 and gly-
oxalase. Price et al. [41] found that resveratrol activates AMP-activated protein kinase 
(AMPK) and increased nicotinamide adenine dinucleotide (NAD) levels in mice. Zhu 
et al. [42] have also shown that, in mice, administration of resveratrol increased the 
antioxidant system (SOD, GPx, and GSH) and also the levels of SIRTI and p-AMPK 
were upregulated in liver. Resveratrol has also been shown to inhibit the activity of 
Cyp2e1 in microsomes of rat liver [43]. Resveratrol also inhibited the activity of P450 
isoform APAP-induced liver injury model [44] and activity of Cyp2e1 was also inhib-
ited in diethylnitrosamine (DEN)-induced hepatocarcinogenesis model [45]. The 
only clinical study that was performed to determine the resveratrol hepatoprotective 
effect demonstrated that a 500 mg resveratrol dose administrated for 12 weeks caused 
a significant reduction in inflammatory cytokines, serum cytokeratin-18, NF-kB acti-
vation, liver alanine aminotransferase (ALT), and hepatic steatosis when compared to 
the placebo group in patients with nonalcoholic fatty liver disease (NAFLD) [46].
1.6 Coffee
Coffee is a mixture of several different molecules such as carbohydrates, vitamins, 
lipids, nitrogenous molecules, alkaloids, and phenolic compounds [47]. Caffeine, 
diterpene alcohols (cafestol and kahweol), and chlorogenic acid are the three major 
compounds found in coffee [48]. Coffee consumption has been linked to the reduc-
tion of several chronic diseases [49], probably due to the pharmacological properties 
that have antinecrotic, antifibrotic, anticholestatic, chemoprotective, and antioxidant 
functions [50]. Caffeine is the best-known active component of coffee, which is 
absorbed very rapidly once it has been taken orally (5 min), reaching its peak blood 
levels after 30 min. When consumed in high amounts, it may produce some side 
effects. Recommendations from Health Canada in 2013 demanded that the daily 
caffeine intake for children should not exceed 2.5 mg/kg of the body weight. What is 
more, tachycardia and arrhythmia typically arise when more than 200 mg of caf-
feine are ingested [51]. Smith et al. [52] reported in 2002 that the intake of 300 mg of 
caffeine resulted in a rise in anxiety and tension. Caffeine gets metabolized in the liver. 
The principal metabolite of caffeine is paraxanthine [53]. An important property of 
caffeine is that it can easily pass through the blood-brain barrier [54]. Coffee-cirrhosis 
relationship was shown by Klatsky et al. for the first time [55]. The study showed that 
the odds ratio for liver cirrhosis tend to decrease from 1.0 for people abstaining from 
coffee to 0.47, 0.23, 0.21, and 0.16 for 1, 2, 3, or 4 cups of coffee daily, respectively. 
Although coffee is generally beneficial to the liver, this study failed to show a causative 
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role of coffee in prevention of liver injury. Therefore, additional basic research and 
controlled prospective studies are needed in order to show exact effect of coffee on 
liver tissue. Arauz et al. [50] demonstrated that coffee has a protective effect upon liver 
injury caused by chronic administration of thioacetamide (TAA). Coffee ameliorated 
cholestasis and necrosis and this was seen by the measurement of γ-glutamyl transpep-
tidase (γ-GTP), alkaline phosphatase, and ALT levels. Arauz et al. [50] demonstrated 
in murine models that coffee prevents experimental liver cirrhosis. In these studies, 
coffee reduced the expression of the profibrogenic cytokine TGF-β. Cavin et al. [56] 
reported coffee to be an inductor of GST, aldo-keto reductase, GSH, HO-1, GST-P1, 
which are enzymes involved in the detoxification process. Also, they suggested that a 
possible mechanism of chemoprotection of coffee by stimulating the Nrf2 pathway. 
In another study, coffee was able to elevate mRNA levels of NQO1 and glutathione-S 
transferase Al in the liver and the small intestine [57].
1.7 Quercetin
Quercetin, 3,3,4,5,7-penta-hydroxyflavone, is a flavonol especially found in 
apples and onions [58]. Quercetin chelates heavy metals and has anticarcinogenic, 
cardioprotective, bacteriostatic, anti-inflammatory, and antioxidant properties [59]; 
it also functions as a hepatoprotective agent [60]. The normal daily intake of querce-
tin is less than 5–40 mg. However, if the peels of the foods that contain high amount 
of quercetin are also consumed, daily intake of quercetin increases to 200–500 mg 
[59]. In 2004, high-purity quercetin used in foods was grass that serves 10–125 mg of 
quercetin [59]. The functional groups responsible for quercetin’s antioxidant activity 
were described by Bors et al. [61] in 1990, and they found that orthodihydroxy or 
catechol groups in the B-ring, a 2,3-double bond of the C-ring, and OH substitution 
on positions 3 and 5 of the C-ring and A-ring, respectively, are important players in 
antioxidant action of quercetin [61]. It can interact with both FR and metal ions like 
Fe3+ and Cu2+ for chelation. In a study by Mira et al. [62], it was reported that reduc-
tion of Fe3+ and Cu2+ takes place by quercetin’s 2,3-double bond and the presence of 
catechol group in the B-ring. Following ingestion, quercetin is rapidly absorbed and 
its levels in blood peak at approximately in 30 min [63] before it is metabolized by 
glucuronidation and sulfation by the UGT and ST, respectively.
In experimental fibrosis model in rats, quercetin showed hepatoprotective 
properties under CCl4 treatment that lasted 8 weeks. The hepatoprotective effect 
of quercetin was found to be mediated by its ability to suppress the expression of 
profibrogenic expressions of TGF-β, CTGF, and collagen-lα (Col-1α). On the other 
hand, quercetin also activated enzymes such as metalloproteinases 2 and 9 (MMP2 
and MMP9); it also improved the activity of SOD and CAT [64]. Pavanato et al. [65] 
extended CCl4 treatment for 16 weeks and also observed that quercetin improved 
the hepatic liver enzymes AST, ALT, and inducible NOS (INOS) expressions; it 
also decreased collagen amount and reduced lipid peroxidation in liver. Granado-
Serrano et al. [66] showed that quercetin modulated Nrf2 and p38 in HepG2 cells. 
Quercetin has also been shown to suppress the activity of Cyp2e1 in hepatocytes in 
the presence of ethanol [67]. In line with this finding, in a nonalcoholic steatohepa-
titis (NASH) model, quercetin was able to reduce Cyp2el activity [68].
1.8 Silymarin
Silymarin, milk thistle or Saint Mary’s thistle, is a natural substance obtained 
from Silybum marianum [7]. Silymarin has not been associated with any side effects 
at acute consumption and the dose range used in literature ranges between 280 and 
800 mg/kg of body weight per day. After oral administration, the silymarin peak 
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plasma concentration is achieved at approximately 6–8 h. The metabolites of silyma-
rin get conjugated in the liver by UGT and ST (phase II reactions) [69]. This substance 
has many hepatoprotective effects (Figure 3). In fact, silybin, a major constituent of 
silymarin, has found to have iron chelating properties [71]. In a study performed by 
Najafzadeh et al. [72], hepatoprotective effect of silymarin in iron-overload-induced 
hepatotoxicity was attributed to its iron-chelator activity; however, no studies have 
proved the chelating properties per se of silymarin in liver diseases. Silymarin acts 
as hepatoprotector against several hepatotoxins including D-galactosamine [73]. 
Silymarin’s ameliorating effects on oxidative stress, fibrosis, cirrhosis, and lipid per-
oxidation are modulated by its phosphatidylethanolamine amount [74]. This hepato-
protective effect is seen with the improvement of liver enzyme activities and levels of 
cholesterol/phospholipids and also sphingomyelin/phosphatidylcholine ratios in the 
membrane [75, 76]. Kim et al. [77] showed that silymarin increases nuclear transloca-
tion of Nrf2 in activated HSC. Also, silymarin increases the activity of antioxidant 
enzymes such as SOD, GPX [78], and CAT [79]. A clinical trial examining silymarin 
in a complex with phosphatidylcholine found reduced levels of the liver enzymes, 
ALT and γ-GGT, and serum bilirubin levels in a dose-dependent manner in patients 
suffering from hepatitis due to virus infection or alcohol abuse [80] (Figure 3).
1.9 Naringenin
Naringenin is also recognized as 5,7,4′-thihydroxyflavanone, and it is a flavanone 
found in citrus fruits and tomatoes [81]. In a recent study, Yang et al. [82] have 
Figure 3. 
A schematic notation of the main pharmacological effects of silymarin in accordance with its hepatoprotective 
features: The effects of Sm upon cell membranes (upper left) and intracellular cascades are shown here. 
The metabolic paths are indicated by interrupted lines, while its signal effects are shown in full lines. LTB4, 
leukotriene B4; GSH, glutathione; NF-kΒ, nuclear factor kappa B; PG’s, prostaglandins; Sm, silymarin; SOD, 
superoxide dismutase; ROS, reactive oxygen types=; TNFa, tumor necrosis factor α [70].
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reported that naringenin did not cause any harmful effects in beagle dogs, the 
maximum time of exposure being 180 days and with doses varying of 20, 100, or 
500 mg/kg body weight per day. Naringenin has many pharmacological properties. 
It acts as a hypolipidemic, antihypertensive, anti-inflammatory, antioxidant, and 
antifibrotic agent [81]. The metabolism of naringenin takes place in small intestine 
where glycoside form of naringenin gets cleaved, resulting in sulfate and glucuro-
nide metabolites in the small intestine wall; then, it gets absorbed [77]. Mira et al. 
[62] showed that naringenin can reduce Fe3+ and Cu2+ ions but it is less potent than 
quercetin. Chtourou et al. [83] found that naringenin averts depletion of SOD, CAT, 
GPx, and GSH. On the other hand, naringenin also prevents an increase in lipid per-
oxidation, and it also prevents increase of enzymes ALT and AST [78]. Yen et al. [84] 
also obtained similar results on liver enzymes and prevention of lipid peroxidation 
when they used naringenin alone and also naringenin-loaded nanoparticle system 
(NARN). In both treatments, naringenin exhibited antioxidant and hepatoprotective 
activities. In these experiments, treatment with naringenin also inhibited the activa-
tion of caspases 3 and 8. However, NARN was found to have better hepatoprotective 
and antioxidant effects than free naringenin, and it was also shown to inhibit caspase 
9 during CC14-induced hepatotoxicity in rats. Han et al. [64] reported that a pre-
treatment with naringenin-7-O-glucoside increases NQO1 and ERK phosphorylation 
and translocation of Nrf2 to the nucleus in H9c2 cardiomyocytes. It also upregulated 
the mRNA expression of GCLC and GCL modifier [64]. Similar findings have 
been reported by Esmaeili et al. [85] who showed that naringenin attenuates CC14-
induced liver injury by downregulating TNF-α, INOS, and cyclooxigenase-2 and also 
by increasing Nfr2 and HO-1 expressions. Motawi et al. [86] showed that naringenin 
inhibits Cyp2e1 in liver microsomal assay done on rats [86].
1.10 Green tea
Camellia sinensis or green tea is a widely consumed beverage across the globe and 
it has antioxidant, anti-inflammatory, antiarthritic, and antiangiogenic effects. It is 
a mixture of polyphenols (the major class of active compounds) including catechins 
(also known as flavan-3-ols) which constitute about 30% (mass fraction) of green 
tea leaves. The major catechins in green tea are (+) -catechin, (−) -epicatechin, (−) 
- epigallocatechin, (−) -epicatechin-3-gallate, (−) -gallocatechin, (−) -gallocatechin gal-
late, and (−) -epigallocatechin-3-gallate (EGCG). EGCG is the most abundant catechin 
accounting for 50% of total polyphenols; thus, it is the main biological active compound 
of green tea [87]. However, polyphenols are not the only compounds that green tea exerts 
its antioxidant activity with through. The amino acid, L-theanine, in green tea accounts 
for 1–2% of the leaf dry weight that is synthetized in the roots of green tea and is 
concentrated in the leaves. Studies have reported that L-theanine protects the cell by 
maintaining its GSH levels in cancer and neurotoxic diseases [88]. The intake of green 
tea can be considered safe unless its consumption exceeds 1–2 cups a day. And higher 
consumption such as in attempts to lose weight resulted in hepatotoxicity [87]. At 
normal doses, Pérez-Vargas et al. [88] found that the main amino acid of green tea, 
L-theanine, reduced expression of NF-kB and downregulated IL-1β and IL-6 and the 
cytokines TGF-β and CTGF. Halegoua-De Marzio et al. [89] tested a single high dose 
of green tea (400 mg), in patients with HCV-induced cirrhosis and found that it is well 
tolerated by patients and beneficial for treating cirrhosis.
1.11 L-Carnitine
L-Carnitine (LC), B-hydroxy-y-trimethylaminobutyric acid, is a water-soluble 
molecule important in mitochondrial oxidation of fatty acids in mammalian 
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metabolism (Figure 4). LC can exist in three different forms: as free LC, acetyl-L-
carnitine (ALC), or other carnitine esters. About 25% of carnitine is obtained from 
methionine biosynthesis, but most LC is provided by the diet, especially through 
red meat and milk consumption [91]. LC acts as a carrier of fatty acids across the 
inner mitochondrial membrane for β-oxidation and ATP production. Apart from its 
role in the lipid metabolism, LC is also a potent antioxidant, and it protects tissues 
from oxidative damage. Reduced concentrations of LC in the body are mostly due to 
the accumulating toxic metabolites and also because of lack of protein in restricted 
diets. Thus, LC supplementation could be useful not only to supply the tissues in 
presence of but also in avoiding oxidative damage as a result of increased amounts 
of reactive species. Since LC can easily cross the blood-brain barrier, LC supple-
mentation may also be beneficial in preventing oxidative injury-related neurological 
damage and further studies are needed in order to clearly establish LC’s role in 
neurological diseases [92].
1.12 Lycopene
Lycopene (LYC) is an acyclic isomer of beta-carotene which has great antioxi-
dant activities. It is synthesized by plants or autotrophic bacteria but not by animals. 
Red fruits and vegetables, such as tomatoes, watermelons, pink grapefruits, apri-
cots, pink guavas, and papaya, contain LYC. Studies show that LYC consumption 
not only reduces the risk of cancer of many organs but also retards the growth of 
tumors. LYC has been shown to have protective effects on other pathologies such 
as cardiovascular diseases, osteoporosis, male infertility, and this action is mainly 
mediated by LC’s ability to inhibit other toxic agents (Figure 5). Numerous in vitro 
Figure 4. 
The mitochondrial carnitine system. Abbreviations: CPT I, carnitine-palmitoyl transferase I; CACT, carnitine 
acyl carnitine transferase; CPT II, carnitine-palmitoyl transferase II; CAT, carnitine acyl transferase; CoA, 
coenzyme A [90].
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and in vivo studies showed that LYC could provide protection against ionizing 
radiation. Therefore, supplementation of LYC might be protective against damaging 
effects of radiotherapy in cancer treatments and it can also be protective against 
accidental radiation exposure [94].
1.13 Piperine
Piperine [1-[5-(1,3-benzodioxol-5-yl)-1-oxo-2,4, pentadienyl] piperidine] is the 
major pungent alkaloid present in the fruits of Piper nigrum L. [95]. Piperine at low 
concentrations acts as a hydroxyl radical scavenger, but at higher concentrations, it 
activates the Fenton reaction, resulting in increased generation of hydroxyl radicals. 
Piperine has hepatoprotective effects and it was shown to inhibit lipid peroxidation 
in the rat liver microsomes at a concentration of 600 μM [96].
1.14 Capsaicin
Capsaicin (trans-8-methyl-N-vanillyl-6-nonenamide) is the major strong and 
irritating ingredient of red pepper. It may inhibit copper ion-induced lipid peroxi-
dation of human LDL, which suggests that it is an effective antioxidant offering 
protection against oxidation of human LDL [97].
Figure 5. 
General mechanisms of action of lycopene. The proposed mechanisms of action of lycopene (oxidative and 
nonoxidative) that decreases the risk of oxidative stress-mediated diseases. Lycopene most likely acts via the 
oxidative mechanism of action to prevent oxidative stress and its detrimental effects on male infertility. ROS: 
reactive oxygen species [93].
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1.15 Garlic and onion
Diallyl sulfides and diallyl disulfides, the active components of garlic, have 
anti-inflammatory and antimutagenic activities. Onion is a major source of fla-
vonoids, especially the two quercetin glycosides, quercetin 4-o-β-glucoside and 
quercetin 3,4-o-β-diglucosides, which are recognized as bioactive substances. In 
order to show the antioxidant properties and protective effects of garlic and onion, 
a study was carried out on rats. Animals were treated with 0.6 mg nicotine/kg and 
also given 100 mg garlic or onion oils/kg for 21 days. Nicotine increased concentra-
tions of thiobarbituric acid, conjugated dienes, and hydroperoxides in the tissues. 
Supplementation with both the garlic oil and onion oil increased resistance not 
only to lipid peroxidation but they also increased levels of antioxidant enzymes 
and glutathione. These conclusions state that oils of garlic and onion are effective 
antioxidants against nicotine-related oxidative stress and damage [98].
1.16 Vitamins C and E
Vitamin C, substrate for ascorbate peroxidase, is not only a highly effective 
antioxidant but also an essential component of a healthy diet. Vitamin E, the major 
antioxidant found in lipid composition of membranes, is a fat-soluble antioxidant. 
During fat oxidization, vitamin E helps to inhibit formation of ROS [99]. Several 
studies showed that vitamin E serum levels are significantly reduced in alcoholic 
liver disease [100]. It is also shown that vitamin E levels are inversely proportional to 
formation of oxidative stress products that correlate with the extent of liver damage 
[101]. For this reason, maintenance of normal concentrations of vitamin E appears 
to be necessary for preventing lipid peroxidation due to alcohol consumption. Works 
from several laboratories have so far indicated that mitochondrial damage may pres-
ent a common early event in cell injury [102]. It is possible to prevent mitochondrial 
damage through vitamin E [103]. Vitamin E or C alone, or in combination, can ease 
scavenging free radicals that are generated in the liver tissue [104]. In the mouse 
model, vitamin E supplementation restores alcohol-induced redox status, reduces 
apoptosis, and prevents oxidative stress [105]. What is more, vitamin E is effective in 
doses of 600 mg daily when it comes to suppressing HBV replication and normaliz-
ing ALT in a significant proportion of chronically infected patients with CLD [106].
1.17 Trace minerals
Trace minerals act as a cofactor of antioxidant enzymes thus enabling the 
antioxidant activities to take place. These trace minerals include selenium (Se), zinc 
(Zn), manganese (Mn), iron (Fe), and copper (Cu) [103]. O2
− radicals are elimi-
nated by the enzyme Cu-Zn-SOD and Cu and Zn are the co-factors for the enzyme. 
One of the enzymes responsible for H2O2 clearance from the cells is CAT and Fe is 
the essential cofactor of this enzyme. Levels of ferritin may decline with exercise 
and increasing dietary or supplemental Fe can improve performance. It was shown 
that moderate-level supplementation of Fe to competitive swimmers increased their 
performance and helped to maintain normal ferritin levels [107]. Selenium (Se) is a 
cofactor for the antioxidant enzyme GPx, which is like the enzyme CAT, responsible 
for removing H2O2 and other organic H2O2 from the cell. A study by Akil et al. [108] 
showed in rats, that upon acute swimming exercise, lipid peroxidation in the brain 
was increased and Se supplementation to these rats increased antioxidant activity 
resulting in inhibition of the free radical production [108]. Manganese (Mn) is a 
cofactor for the enzyme Mn-SOD. It eliminates O2
− radicals produced during oxida-
tive phosphorylation [109].
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2. Conclusion
Investigations done on antioxidants have shown that these compounds are can-
didates for the treatment and candidates to prevent oxidative stress-related diseases. 
This chapter focuses on antioxidants that can be investigated in experimental and 
clinical trials of many diseases but especially in diseases of liver. Main nutritional 
components involved in the production and/or removal of free radicals and the role 
of free radicals in the pathogenesis of several hepatic diseases and related comor-
bidities have been described in this chapter.
Among the antioxidants that were described, curcumin, naringenin, and 
quercetin have been found to be effective antioxidants in treatment of experimental 
liver injury. Green tea has been shown to protect against different kinds of cancer 
in clinical trials but not on hepatocellular carcinoma. Resveratrol has been exten-
sively studied in experimental models of liver diseases and has been shown to have 
protective effects on fibrosis. So far, there are not much clinical trials on ameliorat-
ing and disease preventing effects of most potent antioxidants on liver and these 
antioxidants are good candidates for clinical trials not only because they show great 
disease preventing and ameliorating effects but also because they are derived from 
food sources and have a good metabolic tolerance.
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